Salih HR
Salih HR
Medical Director, KKE Translational Immunology, Department of Internal Medicine, Eberhard Karls University Tübingen
Verified email at
Cited by
Cited by
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
N engl j Med 369, 111-121, 2013
Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding
HR Salih, HG Rammensee, A Steinle
The Journal of Immunology 169 (8), 4098-4102, 2002
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih, H Antropius, F Gieseke, SZ Lutz, L Kanz, HG Rammensee, ...
Blood 102 (4), 1389-1396, 2003
Low-dose decitabine versus best supportive care in elderly patients with intermediate-or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final …
M Lübbert, S Suciu, L Baila, BH Rüter, U Platzbecker, A Giagounidis, ...
Journal of clinical oncology 29 (15), 1987-1996, 2011
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
A Nelde, T Bilich, JS Heitmann, Y Maringer, HR Salih, M Roerden, ...
Nature immunology 22 (1), 74-85, 2021
Platelet-derived transforming growth factor-β down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity
HG Kopp, T Placke, HR Salih
Cancer research 69 (19), 7775-7783, 2009
Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
J Krönke, RF Schlenk, KO Jensen, F Tschürtz, A Corbacioglu, VI Gaidzik, ...
Journal of Clinical Oncology 29 (19), 2709-2716, 2011
Natural killer cell–mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate
S Armeanu, M Bitzer, UM Lauer, S Venturelli, A Pathil, M Krusch, S Kaiser, ...
Cancer research 65 (14), 6321-6329, 2005
Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation
RF Schlenk, S Kayser, L Bullinger, G Kobbe, J Casper, M Ringhoffer, ...
Blood, The Journal of the American Society of Hematology 124 (23), 3441-3449, 2014
Platelet-Derived MHC Class I Confers a Pseudonormal Phenotype to Cancer Cells That Subverts the Antitumor Reactivity of Natural Killer Immune CellsPlatelet MHC Class I Impairs …
T Placke, M Örgel, M Schaller, G Jung, HG Rammensee, HG Kopp, ...
Cancer research 72 (2), 440-448, 2012
Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non-high-risk acute promyelocytic leukemia: final results of the …
U Platzbecker, G Avvisati, L Cicconi, C Thiede, F Paoloni, M Vignetti, ...
Journal of Clinical Oncology 35 (6), 605-612, 2017
Spatial imagery in deductive reasoning: a functional MRI study
M Knauff, T Mulack, J Kassubek, HR Salih, MW Greenlee
Cognitive Brain Research 13 (2), 203-212, 2002
Soluble MICA in malignant diseases
S Holdenrieder, P Stieber, A Peterfi, D Nagel, A Steinle, HR Salih
International journal of cancer 118 (3), 684-687, 2006
Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
AM Paczulla, K Rothfelder, S Raffel, M Konantz, J Steinbacher, H Wang, ...
Nature 572 (7768), 254-259, 2019
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
RF Schlenk, D Weber, W Fiedler, HR Salih, G Wulf, H Salwender, ...
Blood, The Journal of the American Society of Hematology 133 (8), 840-851, 2019
More than just tumor destruction: immunomodulation by thermal ablation of cancer
SP Haen, PL Pereira, HR Salih, HG Rammensee, C Gouttefangeas
Clinical and Developmental Immunology 2011, 2011
Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival
MP Radsak, HR Salih, HG Rammensee, H Schild
The Journal of Immunology 172 (8), 4956-4963, 2004
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors
PK Epling-Burnette, F Bai, JS Painter, DE Rollison, HR Salih, M Krusch, ...
Blood, The Journal of the American Society of Hematology 109 (11), 4816-4824, 2007
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
SK Metzelder, T Schroeder, A Finck, S Scholl, M Fey, K Götze, YC Linn, ...
Leukemia 26 (11), 2353-2359, 2012
Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses
J Hilpert, L Grosse-Hovest, F Grünebach, C Buechele, T Nuebling, ...
The journal of immunology 189 (3), 1360-1371, 2012
The system can't perform the operation now. Try again later.
Articles 1–20